Trial Profile
Single-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Safety, PK, and; Efficacy of a Single Oral Dose of XPF-001 in the Treatment of Pain Related to Third Molar/Wisdom Tooth Extraction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jul 2012
Price :
$35
*
At a glance
- Drugs Funapide (Primary)
- Indications Dental pain
- Focus Therapeutic Use
- 28 Jun 2012 Actual patient number is 61 according to ClinicalTrials.gov.
- 09 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 25 Aug 2009 New trial record